20-1305444-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001318234.2(SNPH):c.1007C>A(p.Thr336Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000539 in 1,613,248 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00030 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000029 ( 0 hom. )
Consequence
SNPH
NM_001318234.2 missense
NM_001318234.2 missense
Scores
5
14
Clinical Significance
Conservation
PhyloP100: 2.13
Genes affected
SNPH (HGNC:15931): (syntaphilin) Syntaxin-1, synaptobrevin/VAMP, and SNAP25 interact to form the SNARE complex, which is required for synaptic vesicle docking and fusion. The protein encoded by this gene is membrane-associated and inhibits SNARE complex formation by binding free syntaxin-1. Expression of this gene appears to be brain-specific. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.094148785).
BS2
High AC in GnomAd4 at 45 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SNPH | NM_001318234.2 | c.1007C>A | p.Thr336Asn | missense_variant | 7/7 | ENST00000381867.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SNPH | ENST00000381867.6 | c.1007C>A | p.Thr336Asn | missense_variant | 7/7 | 1 | NM_001318234.2 | P3 | |
SNPH | ENST00000614659.1 | c.1007C>A | p.Thr336Asn | missense_variant | 4/4 | 1 | P3 | ||
SNPH | ENST00000381873.7 | c.875C>A | p.Thr292Asn | missense_variant | 6/6 | 1 | A1 | ||
SNPH | ENST00000649598.1 | c.974C>A | p.Thr325Asn | missense_variant | 6/6 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152272Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
44
AN:
152272
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000640 AC: 16AN: 250132Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135584
GnomAD3 exomes
AF:
AC:
16
AN:
250132
Hom.:
AF XY:
AC XY:
5
AN XY:
135584
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000288 AC: 42AN: 1460858Hom.: 0 Cov.: 36 AF XY: 0.0000234 AC XY: 17AN XY: 726746
GnomAD4 exome
AF:
AC:
42
AN:
1460858
Hom.:
Cov.:
36
AF XY:
AC XY:
17
AN XY:
726746
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000295 AC: 45AN: 152390Hom.: 0 Cov.: 34 AF XY: 0.000295 AC XY: 22AN XY: 74520
GnomAD4 genome
AF:
AC:
45
AN:
152390
Hom.:
Cov.:
34
AF XY:
AC XY:
22
AN XY:
74520
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
4
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
10
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2023 | The c.875C>A (p.T292N) alteration is located in exon 6 (coding exon 4) of the SNPH gene. This alteration results from a C to A substitution at nucleotide position 875, causing the threonine (T) at amino acid position 292 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;N;.
REVEL
Benign
Sift
Benign
.;T;T;.
Sift4G
Benign
.;T;T;T
Polyphen
1.0
.;D;D;D
Vest4
0.49, 0.34, 0.33
MVP
0.17
MPC
1.4
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at